New drug combo and High-Tech scans tested to fight prostate cancer
NCT ID NCT03860987
Summary
This study is testing a combination of three hormone-blocking drugs given to men before prostate removal surgery. The goal is to see if this approach better controls the cancer. Researchers are also using advanced PET and MRI scans to see if they can more accurately detect and monitor the cancer's response to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATE SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.